Abstract-Endothelin (ET)-1, an endothelium-derived vasoconstrictor and mitogen, acts as an antiapoptotic factor against serum deprivation-induced apoptosis of endothelial cells and fibroblasts but enhances apoptosis of some cancer cells.
A poptosis, a genetically controlled cell death program, is an important determinant of cell number under physiological and certain pathological conditions. Apoptosis is associated with distinct morphological and biological events, such as cellular shrinkage, membrane blebbing, and chromatin condensation and fragmentation. Apoptosis is under the control of environmental stimuli, such as serum deprivation, irradiation, chemotherapeutic agents, and antioxidants, 1 whereas certain growth factors and cytokines are known to inhibit apoptosis. 2, 3 Overexpression of c-Myc protein combined with serum deprivation induces apoptosis in several cell types, including vascular smooth muscle cells (VSMCs). 4, 5 Using diploid fibroblast cell lines with 1 endogenous c-myc gene copy knocked out by gene targeting, we recently demonstrated that serum deprivation-induced apoptosis is dependent on endogenous c-myc expression, 6 suggesting that cells without ectopic oncogene overexpression may also undergo apoptosis in the event of growth factor shortage. To date, 2 general models have been proposed for apoptosis induced by serum deprivation: (1) a conflict of growth-promoting and growth-inhibitory signals triggers apoptosis, 7 and (2) c-Myc directly activates an apoptotic pathway whose execution is regulated by the availability of survival factors. 2 A potent endothelium-derived relaxing factor, nitric oxide (NO), has also been implicated in the regulation of apoptosis. Whether NO induces or suppresses apoptosis appears to depend on species or cell type, or alternatively, on experimental design. In macrophages, 8 thymocytes, 9 tumor cells, 10 and pancreatic ␤-cells, 11 NO is proapoptotic, whereas in lymphocytes and lymphoma cells, NO functions as a survival-promoting factor. 12, 13 In cultured VSMCs, NO donor has been reported to inhibit proliferation 14 and induce apoptosis. 15, 16 We recently confirmed the apoptotic effects of excess NO on VSMCs after transfection of rat inducible NO synthase gene. 17 Endothelin (ET)-1, a potent vasoconstrictor peptide originally isolated from the vascular endothelium, regulates vascular remodeling as well as vascular tonus. 18 Despite the distinct function of ET-1 as a vasoconstrictor and mitogen, its role as a modulator of apoptosis remained unappreciated until we found that ET-1 suppresses serum deprivation-induced apoptosis of rat fibroblasts 6 and endothelial cells 19 as well as NO donor-induced apoptosis of rat endothelial cells. 20 In contrast, it has been reported that ET-1 enhances apoptosis of human melanoma cell lines. 21 Accumulating evidence suggests that both ET-1 and NO are involved in the process of vascular remodeling, migration, proliferation, and extracellular matrix accumulation of VSMCs. 22, 23 A close interaction between ET-1 and NO is thought to reduce the magnitude of their opposing actions, such as regulation of vascular tonus; ET-1 stimulates NO production, 24 whereas NO inhibits ET-1 production in endothelial cells. 25 However, little information is available on whether ET-1 and NO interact with each other to affect cell survival or apoptosis of VSMCs. Therefore, the present study was designed to determine whether (1) ET-1 affects apoptosis of VSMCs induced by serum withdrawal and NO and (2) the mitogen-activated protein (MAP) kinase pathway is involved in the mechanism of the cell survival effect of ET-1 in VSMCs. 
Methods

Materials
] by Fujisawa Pharmaceutical. PD98059 was purchased from Amersham International and S-nitroso-N-acetyl penicillamine (SNAP) from Biomol Research Laboratories. All other compounds or reagents were of molecular biology grade. The plasmids MAP kinase kinase-1 (MAPKK1) WT, an unphosphorylated wild-type MAPKK1 expressed from the SV40 early promoter; MAPKK1 S218D/S222D, a constitutively activated form; and MAPKK1 S222A, a dominantinterfering form were kindly provided by Drs Anne Brunet and Jacques Pouyssegur (Centre de Biochime-CNRS, Université de Nice, France). 26 
Cell Culture
Rat aortic VSMCs were prepared by the explant method as reported previously 27 and cultured in DMEM supplemented with 10% FBS in 5% CO 2 atmosphere at 37°C in a Costar Polystyrene dish or multiwell plates (Corning Inc), and the cells (6th to 12th passages) were used in the experiments. To produce apoptosis by serum deprivation, cells were washed with PBS, the medium was replaced with serum-free DMEM, and the cells were incubated for the indicated times. To elicit NO-induced apoptosis, medium was replaced with DMEM supplemented with 1% FBS containing FK409 or SNAP, and the cells were incubated for the indicated times.
Transfection
Transient transfection was performed with the synthetic cationic liposome (ϩ)-N,N-[bis(2-hydroxyethyl)-N-methyl-N-[2,3-di(tetradecanoyloxy)propyl] ammonium iodide according to instructions provided by the supplier (Promega) with the following modification using transferrin-receptor-operated transfer. 28 In brief, 3 L of liposome was added to 100 L HEPES-buffered saline (20 mmol/L HEPES, pH 7.4, and 100 mmol/L NaCl) containing 16 g human holo-transferrin (Sigma Chemical Co), incubated for 20 minutes at room temperature, mixed with 100 L HEPES-buffered saline containing various amounts of DNA mixtures, and further incubated for 15 minutes. DNA-liposome-transferrin complex was then overlaid on cells that had been covered with serum-free DMEM and incubated for 2 hours. 19 DNA-liposome complex was confirmed to form multilamellar vesicles known to exert high transfection efficiency. 29, 30 To determine the transfection efficiency, ␤-galactosidase-expressing construct was introduced in the same manner as indicated above. Regardless of the DNA concentrations used (0.05 to 1 g/well), nearly 100% of total cells were transfected, and the intensity of the reporter signal correlated well with the DNA concentrations used (data not shown).
Detection of Apoptosis
For demonstration of nucleosomal ladders, cellular fragmented DNA was extracted by the NP-40 lysis method, which efficiently eliminates intact chromatin. 31 Floating and/or adherent VSMCs in 10-cm dishes were collected, and apoptotic DNA fragments were extracted with NP-40, fractionated on 1.6% agarose gel electrophoresis, and stained with ethidium bromide as reported previously. 6, 19, 32 Both floating and adherent cells were stained for free 3Ј-hydroxyl ends of DNA fragments with dUTP-FITC with an APO-DIRECT apoptosis detection kit (PharMingen) and counterstained for total DNA content with propidium iodide. Stained cells were then analyzed with a FACS Calibur flow cytometer (Becton-Dickinson). 33 Apoptotic cells were also detected in situ by the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) method using an in situ cell death detection kit (Takara Biomedicals) as described previously. 6 In brief, cells grown on LAB-TEK Chamber Slides (Nalge Nunc International) were fixed for 15 minutes in 4% paraformaldehyde in PBS, blocked for 15 minutes with 0.3% H 2 O 2 in methanol, washed, and permeabilized for 2 minutes with 0.1% sodium citrate in PBS, followed by sequential exposure to the enzymatic reaction mixture for 60 minutes at 37°C, anti-FITC horseradish peroxidase conjugate for 30 minutes at 37°C, and 0.05% diaminobenzidine in 1% nickel sulfate and 0.01% H 2 O 2 . To quantify the extent of apoptosis, we calculated the percentage of TUNEL-positive cells relative to total cell population by counting all cells from 5 random microscopic fields at a magnification of ϫ100.
Enumeration of Viable and Floating Apoptotic Cells
Rat VSMCs plated in 24-well dishes (10 4 cells per well) were incubated in DMEM containing 10% FBS for 48 hours. The cells were extensively washed with PBS, then incubated in fresh DMEM supplemented or unsupplemented with 1% FBS, in the presence of the compounds tested. After 24 hours, all floating cells were collected after 2 washes with PBS. All adherent cells were also collected after trypsinization for quantitative analysis of total apoptotic events in a given cell population, 6, 19 and the numbers of the floating and adherent cells were determined with a Sysmex CDA-500 Autoanalyzer (Toa Medical Electronics).
Determination of MAP Kinase Activity
An extracellular signal-regulated kinase (ERK)/MAP kinase-dependent reporter system (PathDetect Trans-Reporting System, Stratagene) was used to measure MAP kinase activity. The system includes the fusion activator plasmids that consist of the DNAbinding domain of the yeast GAL4 fusion activator (pFR-Luc) and the activation domain of the Elk1 transcription factor (pFC2-Elk1). Cells plated in 96-well plates were cotransfected with pFC2-Elk1 (50 ng each per well), pFR-Luc reporter plasmid (1 g each per well), pRL-TK vector (1 g each per well) (Promega) expressing Renilla luciferase as an internal control, and with or without MAPKK mutants as indicated in the text. The cells were incubated for 24 hours after transfection in DMEM containing 10% FBS, switched to serum-free medium for an additional 24 hours, pretreated or untreated with PD98059 for 1 hour, and then treated with ET-1 for the indicated time, after which firefly and Renilla luciferase activities were measured with the Dual Luciferase Reporter Assay System (Promega) in a single-tube assay format using MicroLumat Plus (EG&G Berthold). 34 The firefly luciferase activity of each sample was normalized to an internal reference standard of Renilla luciferase activity.
precooled cell lysis buffer. Lysates were centrifuged at 15 000 rpm at 4°C for 20 minutes, and protein concentrations were determined (Pierce Chemical Co). Extracts were stored at Ϫ80°C until assayed. Aliquots of protein (25 g) were incubated with 2 mol/L of the caspase-3 substrate Ac-DEVD-p-nitroaniline in a total volume of 100 mol/L at 37°C for 4 hours. The colorimetric release of p-nitroaniline from the Ac-DEVD-pNA substrate was recorded at 405 nm. Enzymatic activity for caspase-3 was linear over the range of protein concentrations used to calculate the specific activity.
Statistical Analysis
Data are expressed as meanϮSEM. Statistical analysis was performed by unpaired Wilcoxon's t test. A value of PϽ0.05 was considered statistically significant.
Results
ET-1 Inhibits Serum Deprivation-Induced Apoptosis of VSMCs
After serum deprivation, a fraction of VSMCs started to show morphological features characteristic of apoptosis, such as membrane blebbing, cellular shrinkage, nuclear condensation and fragmentation, followed by detachment from the culture plates. By the NP-40 lysis method, which efficiently eliminates intact chromatin, 31 fragmented DNA was extracted from all floating and adherent VSMCs after serum deprivation for 6 to 24 hours and subjected to agarose gel electrophoresis. Nucleosomal ladders in DNA samples extracted from serum-deprived VSMCs were visible as early as 6 hours, whereas the addition of ET-1 in higher concentrations (10 Ϫ9 to 10 Ϫ6 mol/L), but not in lower concentrations (10 Ϫ12 to 10 Ϫ10 mol/L), resulted in a dose-dependent inhibition of DNA fragmentation ( Figure 1A ). VSMCs were analyzed by flow cytometry using cells stained for free 3Ј-hydroxyl ends of DNA with FITC. When floating and adherent cells were analyzed separately 24 hours after serum deprivation, adherent cells contained a limited number of positive cells, whereas floating cells were apoptotic ( Figure 1B) . Few apoptotic cells were detected among growing VSMCs incubated in DMEM containing 10% FBS. Apoptosis increased markedly after serum deprivation, whereas ET-1 (10 Ϫ7 mol/L) markedly suppressed the fraction of apoptotic cells. These results indicate that serum deprivation induces apoptosis of VSMCs and ET-1 inhibits serum deprivation-induced apoptosis.
To determine which receptor subtype (ET A , ET B ) is responsible for the antiapoptotic effect of ET-1, we examined the effects of several ET receptor antagonists on serum deprivationinduced VSMC apoptosis ( Figure IA 
ET-1 Inhibits NO-Induced Apoptosis of VSMCs
We next examined whether ET-1 inhibits NO-induced apoptosis of VSMCs. Minimal nucleosomal laddering was noted in DNA samples extracted from VSMCs incubated with 1% FBS during 24 hours. In contrast, the addition of a potent NO donor, FK409 (10 Ϫ4 mol/L), caused a distinct nucleosomal ladder, whose effect was abrogated by coincubation with ET-1 (10 Ϫ7 to 10 Ϫ6 mol/L) ( Figure IIA, online) . These findings were further confirmed by flow cytometric analysis ( Figure 
Antiapoptotic Effect of ET-1 Is Mediated by MAP Kinase Activation
Because the intracellular signaling mechanism that mediates antiapoptosis involves the MAP kinase pathway in PC-12 cells, 35 we examined whether ET-1 activates MAP kinase in rat VSMCs. ET-1 (10 Ϫ7 mol/L) stimulated MAP kinase activity in VSMCs deprived of serum for 48 hours. Further experiments showed that this effect was concentrationdependent (10 Ϫ8 to 10 Ϫ6 mol/L, Figure IVA , online). The results were confirmed by phosphorylation of p42 and p44 as demonstrated by immunoblot analysis using antiphosphotyrosine antibody and by enzyme activity data obtained with an in vitro p42/p44 kinase assay system (Amersham) using [␥-
32 P]ATP (data not shown). 6 Moreover, FK409 dose-dependently (10 Ϫ5 to 10 Ϫ4 mol/L) reduced MAP kinase activity stimulated by ET-1 (10 Ϫ7 mol/L) ( Figure IVA,  online) . In contrast to quiescent VSMCs, a higher dose of FK409 was necessary to antagonize MAP kinase activation induced by ET-1 (10 Ϫ7 mol/L) in cells maintained in 1% FCS (data not shown).
We next examined whether the MAPKK-1/MAP kinase pathway is involved in the ET-1-induced survival effect. Pretreatment with PD98059 (10 Ϫ5 mol/L), a specific inhibitor of MAPKK-1, blocked the increase in MAP kinase activation induced by ET-1 (10 Ϫ7 mol/L) ( Figure IVA, online) and antagonized the survival effect of ET-1 on apoptosis induced by both serum deprivation and FK409 as evaluated by nucleosomal laddering (Figure 2A) . Transfection of VSMCs with a constitutively activated form of MAPKK-1 (MAPKK-1 S218D/S222A) and an unphosphorylated wildtype MAPKK-1 expressing DNA construct (MAPKK-1 WT) to a lesser degree rescued VSMCs from apoptosis induced by serum deprivation and by FK409 (10 Ϫ4 mol/L) (Figure 3 ), suggesting the involvement of MAP kinase in serum deprivation-induced apoptosis. Transfection of VSMCs with MAPKK-1 S222A, a dominant-negative construct, resulted in a complete blockade of MAP kinase activation induced by ET-1 ( Figure IVB, online) and abolished the preventive effect of ET-1 from both serum deprivation-and FK409-induced apoptosis, whereas empty vector was without effect ( Figure  2B ). These results suggest the important role of the MAPKK-1/MAP kinase pathway in the ET A receptor-mediated survival effect in both serum deprivation-and NO-induced apoptosis of VSMCs.
Regulation of Caspase-3 Activation by Serum Deprivation, NO, and ET-1
To exclude the possibility that apoptosis may be secondarily triggered by cell detachment from substrate (anoikis), we measured caspase-3 activity using adherent VSMCs after serum deprivation and addition of NO donors. Both serum deprivation ( Figure 4 ) and NO donors (FK409, SNAP) ( Figures 5 and 6 ) increased caspase-3 activity, reaching a peak level at 30 to 60 minutes; the effects of FK409 and SNAP were dose-dependent (10 Ϫ6 to 10 Ϫ4 mol/L) (data not shown). FK409 and SNAP decayed spontaneously within 24 hours and did not induce caspase-3 activity. Coincubation of ET-1 (10 Ϫ7 mol/L) suppressed the increase in caspase-3 activity, and this effect was antagonized by pretreatment with PD98059 (10 Ϫ5 mol/L) (Figures 4, 5, and 6 ). These results confirm that apoptosis induced by serum deprivation and NO is not a consequence of cell detachment but rather their direct effects via activation of caspase-3 pathway.
Discussion
In the present study, apoptosis of cultured rat VSMCs was induced by serum deprivation, potent NO donors, FK409, and SNAP. Occurrence of apoptosis was evidenced by (1) nucleosomal ladders on agarose gel electrophoresis by the NP-40 lysis method, (2) positive staining for free 3Ј-hydroxyl ends of DNA fragments by flow cytometry, (3) positive staining with the in situ TUNEL method, and (4) increased caspase-3 activity. Because the NP-40 lysis method very efficiently eliminates intact chromatin, the final extracted sample before agarose gel electrophoresis should contain only fragmented DNA, whereas samples free of apoptotic cells result in very low DNA yield. FK409, (Ϯ)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide, is a novel and potent NO donor that spontaneously releases NO under neutral aqueous conditions with a half-life of 46 minutes. 36 Addition of media to which FK409 or SNAP had been added and has decayed spontaneously did not induce apoptosis. These data are compatible with those of recent studies from our laboratory showing that FK409 induced apoptosis of rat endothelial cells without any effect via its decomposition product(s). 20 We have also shown that transfection of the inducible NO synthase gene into rat VSMCs caused massive apoptosis, whose effect was blocked by a nonselective NO synthase inhibitor, N G -monomethyl-L-arginine. 17 Considered together, these observations suggest that massive NO and serum deprivation may function as important determinants of the number of VSMCs by inducing apoptosis. Lower doses of FK409 or SNAP induced limited apoptosis, implying limited contributions of small amounts of NO in negative vascular remodeling.
The phenomenon that apoptosis is triggered by detachment of cells from the supportive substrates (anoikis) is an established feature of endothelial cells. 19 ,37 Therefore, we examined whether serum deprivation and NO primarily induced cell detachment and that the observed apoptosis was a secondary feature rather than the direct effect of NO on the cell death mechanism. We found that many adherent cells remained TUNEL-positive when fixed without being washed ( Figures IB and IIIA, online) , whereas the number of TUNEL-positive cells diminished when extensively washed before fixation. Moreover, serial phase-contrast microscopic examination revealed that cells first showed morphological features of apoptosis and then detached later. These observations were further confirmed by the findings that both serum deprivation and NO induced caspase-3 activity in adherent VSMCs as early as 30 to 60 minutes before the development Ϫ7 mol/L) for 6 hours. Fragmented DNAs extracted from total VSMC culture was subjected to agarose gel electrophoresis as described in Figure 1A . B, Subconfluent cells were transfected with empty vector or dominant-negative MAPKK-1 (S222A) under serum deprivation (left) or with FK409 (10 Ϫ4 mol/L) (right) in DMEM containing 1% FBS and incubated for 6 hours in the presence and absence of ET-1 (10 Ϫ7 mol/L). Fragmented DNAs were extracted from total VSMC culture as described in Figure 1A .
of apoptosis. Considered together, the results indicate that apoptosis observed in the present study is not due to cell detachment but rather to the direct effect on cell death mechanisms. Therefore, calculation of floating/total cell ratio by counting both floating and adherent cell numbers after extensive washes truly represents the approximate percentage of apoptotic cells in a given VSMC population.
The antiapoptotic effect of ET-1 against serum deprivation-and NO-induced apoptosis of rat VSMCs was confirmed by the following experiments: (1) suppression of nucleosomal ladders, (2) reduction in the number of in situ TUNEL-positive cells among adherent cells, (3) reduction of positively stained cells by flow cytometry analysis, (4) reduced number of floating dead cells, and (5) suppression of caspase-3 activity in adherent cells. The dose-dependent inhibition of apoptosis by ET-1 (10 Ϫ11 to 10 Ϫ8 mol/L) is almost comparable to that in rat fibroblasts 6 and endothelial cells, as recently described. 19 Because ET-1 suppressed the increase in caspase-3 activity induced by serum deprivation and NO, the antiapoptotic effect of ET-1 is not due to its indirect influence on suppression of cell detachment but rather represents a direct antagonism against cell death. Given the paracrine/autocrine action of ET-1 secreted mainly by endothelial cells on neighboring VSMCs, our findings suggest a novel role for endothelium-derived ET-1 as a potent survival factor for VSMCs against apoptosis.
The diverse effects of ET isopeptides (ET-1, ET-2, ET-3) are mediated by 2 distinct receptor subtypes (ET A , ET B ) of G protein-coupled receptors expressed in a wide variety of tissues. 38, 39 VSMCs mainly express ET-1-selective ET A receptors, which mediate contraction, whereas vascular endothelial cells express non-isopeptide-selective ET B receptors, which mediate vasodilation via generation of NO. 24 In the present study, both ET A receptor antagonist (BQ123) and nonselective ET A/B receptor antagonist (TAK044), but not ET B receptor antagonist (BQ788), completely blocked the protective effect of ET-1 against apoptosis induced by serum deprivation and NO. Furthermore, BQ3020, another ET B receptor agonist, failed to suppress apoptosis of VSMCs. These results indicate that the cell survival effect of ET-1 is mediated via the ET A receptor.
ET receptor antagonists have been reported to prevent vascular hypertrophy 40 and postangioplasty-induced neointima formation in rats. 41, 42 However, because of the apparent discrepancy between inhibition of ET-1-induced mitogenic activity and the protective effect against neointima formation by ET receptor antagonists, a mechanism(s) other than mitogenic activity of ET-1 has been strongly suggested. 42 In Figure 3 . MAPKK-1/MAP kinase suppresses apoptosis induced by serum deprivation and NO. Subconfluent cells were transfected with empty vector, wild-type unphosphorylated MAPKK-1 (WT), the constitutively activated form of MAPKK-1 (S218D/S222D), or dominantnegative MAPKK-1 (S222A) and then serum-deprived or treated with FK409 (10 Ϫ4 mol/L). Fragmented DNAs were extracted from total VSMC culture as described in Figure 1A .
this regard, induction of apoptosis by blockade of ET A receptor may be an important mechanism that explains the potent inhibitory action of ET receptor antagonists in experimental vascular diseases, considering that elimination of apoptotic VSMCs may determine the course of atherosclerosis. 43 We have recently shown that endogenous ET-1 secretion by rat endothelial cells protects these cells against serum deprivation-induced apoptotic death via the ET B receptor in an autocrine/paracrine fashion, 19 whereas ET-1 suppresses apoptosis via the ET A receptor in rat fibroblasts. 6 Because endothelial cells actively synthesize and secrete ET-1, it is most likely that endogenous ET-1 protects not only endothelial cells but also VSMCs from apoptosis in an autocrine/ paracrine manner.
The MAP kinase pathway plays a central role in cell proliferation and differentiation. In the present study, ET-1 stimulated MAP kinase activity in quiescent VSMCs in a dose-dependent manner. The effect was significantly suppressed by cotreatment with FK409, suggesting counterregulatory functions of ET-1 and NO in activation/suppression of MAP kinase in VSMCs. Activation of MAP kinase has been shown to inhibit apoptosis in PC-12 cells deprived of nerve growth factor, 35 in ceramide-treated HL60 cells, 44 and in potassium-deprived cerebellar neurons. 45 Raf-1 activation has been shown to protect Rat-1 fibroblasts against c-Myc-induced apoptosis, 46 whereas a contrasting report suggests the proapoptotic role of a Raf-MAP kinase pathway in fibroblasts. 47 Furthermore, it was recently reported that ET-1 enhances apoptosis via ET B receptor-mediated p53 induction in human melanoma. 21 In contrast, ET B receptors mediate suppression of endothelial apoptosis induced by serum deprivation not involving the MAP kinase pathway, 19, 48 whereas ET A receptors protect fibroblasts against serum deprivation-induced apoptosis via activation of MAP kinase. 6 Thus, the involvement of the MAP kinase pathway in ET-1-induced apoptosis/ antiapoptosis may depend on cell type and receptor subtype. The present study demonstrated that inhibition of MAP kinase by a specific MAPKK-1 inhibitor (PD98059) as well as transfection of a dominant-interfering MAPKK-1 mutant abrogated the antiapoptotic effect of ET-1, whereas overexpression of MAPKK1 potently antagonized apoptosis. These results strongly suggest the involvement of the MAPKK-1/MAP kinase pathway in ET A receptor-mediated protection against apoptosis of VSMCs. However, it remains to be determined whether NO inhibits Raf-1/MAPKK-1/MAP kinase and/or inactivates MAP kinase via MAP kinase phosphatase-1.
In conclusion, we have demonstrated for the first time that the counterbalance between an endothelium-derived relaxing factor, NO, and an endothelium-derived vasoconstrictor peptide, ET-1, determines VSMC elimination by apoptosis and cell survival, respectively. Imbalances between these 2 endothelium-derived vasoactive factors may occur under certain pathological conditions, such as in atherosclerosis, hypertension, and restenosis after vascular injury, thereby leading to dysregulation of cell survival.
